Research
Molecular
The use of nano-based medications through transdermal delivery is important for effective obesity treatment.
Practitioners should consider incorporating nano-based medications for better treatment outcomes.
StrongSupportsmedium confidence
the importance of the use of nano-based medications through transdermal delivery.
Why this rating
The abstract discusses current treatment strategies and challenges.
Source
Role of Microneedles for Improved Treatment of Obesity: Progress and Challenges
Sudarshan Naidu Chilamakuri et al. · Molecular Pharmaceutics · 2025
DOI 10.1021/acs.molpharmaceut.4c01115
reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Microneedle (MN)-based technologies provide a painless drug delivery approach that targets adipose tissue directly, minimizing systemic exposure and reducing the required dosage.Strong
- MNs hold promise in improving the quality of life for individuals struggling with obesity and its associated comorbidities.Strong
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →